IL6 and neoplasm: Moreover, by inhibiting pro-inflammatory cytokines like IL-6 and TNF-α in the TME, AE can mitigate chronic, tumor promoting inflammation and modulate the activities of other immune cells, including T cells and dendritic cells, thus establishing a microenvironment detrimental to tumor proliferation (Qu et al., 2025; Yin et al., 2025).